MedTrace Logo

HemoControl System Activated in Hemodiafiltration Treatments

NCT01582867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-03-13

No results posted yet for this study

Summary

The current study aims to assess the HemoControl prescription in On-Line Hemodiafiltration treatment.

Conditions

  • Renal Failure

Interventions

DEVICE

ARTIS hemodialysis system

Software versions: Control Product: 8.06.01KA. Study Product: 8.06.01B\_HC01

Sponsors & Collaborators

  • Gambro Dasco S.p.A.

    collaborator INDUSTRY

  • Baxter Healthcare Corporation

    collaborator INDUSTRY

  • Vantive Health LLC

    lead INDUSTRY

Principal Investigators

  • Antonio Santoro, Dr. · POLICLINICO SANT'ORSOLA MALPIGHI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01582867 on ClinicalTrials.gov